1. Home
  2. PATK vs TARS Comparison

PATK vs TARS Comparison

Compare PATK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$107.00

Market Cap

3.4B

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$81.92

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATK
TARS
Founded
1959
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PATK
TARS
Price
$107.00
$81.92
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$105.78
$73.63
AVG Volume (30 Days)
254.1K
388.0K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
1.48%
N/A
EPS Growth
N/A
N/A
EPS
3.51
N/A
Revenue
$3,872,728,000.00
$366,100,000.00
Revenue This Year
$6.55
$147.24
Revenue Next Year
$5.08
$53.11
P/E Ratio
$30.76
N/A
Revenue Growth
6.08
182.44
52 Week Low
$72.99
$38.51
52 Week High
$116.78
$83.47

Technical Indicators

Market Signals
Indicator
PATK
TARS
Relative Strength Index (RSI) 56.64 67.09
Support Level $104.86 $77.44
Resistance Level $110.24 $83.47
Average True Range (ATR) 3.45 3.62
MACD 0.60 0.12
Stochastic Oscillator 77.35 87.65

Price Performance

Historical Comparison
PATK
TARS

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: